Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Why is Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 19.70% and Operating profit at 35.46% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 273.58 MM
ROCE(HY) Highest at 17.59%
NET SALES(Q) Highest at CNY 336.46 MM

With ROE of 16.38%, it has a fair valuation with a 4.73 Price to Book Value

Over the past year, while the stock has generated a return of 71.32%, its profits have risen by 35%

Market Beating performance in long term as well as near term

Along with generating 71.32% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. should be less than 10%
Overall Portfolio exposure to FMCG should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

61.64%

-0.08

52.61%

China Shanghai Composite

15.44%

1.01

14.52%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.70%

EBIT Growth (5y)

35.46%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.56

Tax Ratio

10.65%

Dividend Payout Ratio

19.23%

Pledged Shares

Institutional Holding

ROCE (avg)

14.36%

ROE (avg)

13.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.73

EV to EBIT

25.11

EV to EBITDA

18.95

EV to Capital Employed

5.35

EV to Sales

6.58

PEG Ratio

Dividend Yield

ROCE (Latest)

21.30%

ROE (Latest)

16.38%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 273.58 MM

ROCE(HY)

Highest at 17.59%

NET SALES(Q)

Highest at CNY 336.46 MM

PRE-TAX PROFIT(Q)

Highest at CNY 105.07 MM

NET PROFIT(Q)

Highest at CNY 89.17 MM

-8What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 0 %

RAW MATERIAL COST(Y)

Grown by 103.19% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 0%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0%

OPERATING PROFIT(Q)

Lowest at CNY -109.57 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -32.56 %

EPS(Q)

Lowest at CNY 0

Here's what is working for Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Operating Cash Flow

Highest at CNY 273.58 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 336.46 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 105.07 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 89.17 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Here's what is not working for Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Debt-Equity Ratio

Highest at 0 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY -109.57 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -32.56 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

EPS

Lowest at CNY 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Lowest at 0%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 103.19% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales